mAbxience actively participated in the 2nd National Conference on Biosimilars organised by the Spanish Biosimilar Medicines Association, BioSim. The conference, entitled “Biosimilars: evidence and efficiency”, took place at the Ministry of Health, Social Services and Equality in Madrid on 21st February.

Francisco Olivera, Operations Manager at mAbxience León, shared the “Evidence: from R&D to authorisation” table with Antonio Blázquez, of the Spanish Agency of Medicines and Medical Devices (AEMPS) and Alfonso Moreno, Chair of the BioSim Ethics Committee. Francisco introduced his presentation, “R&D and Production of biosimilars”, with an educational video in which he explained how we develop and manufacture our biosimilars, followed by an explanatory talk which covered the development up to the marketing of our products.